Regeneron Pharmaceuticals, Inc. et al. vs. Novartis Pharma AG et al.
Explore the PTAB proceeding IPR2020-01318 filed by Regeneron Pharmaceuticals, Inc. et al. on 2020-07-16. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2020-01318
Filing Date
2020-07-16
Accorded Filing Date
2020-07-16
Institution Decision Date
โ
Last Modified Date
2025-02-14
Proceeding Type
IPR
Termination Date
2020-12-07
Trial Status
Terminated
Parties & Counsel
Petitioner
Regeneron Pharmaceuticals, Inc. et al.
Represented By
Weiswasser, Elizabethet alPatent Owner / Respondent
Novartis Pharma AG et al.
Represented By
Holland, Elizabethet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 3700 - Mechanical Engineering & Manufacturing
Decisions Rendered
1 Total
Proceeding Status
Terminated
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 39030 | Jean Silveri | +1 617-871-5134 |
| 40232 | Timothy Witkowski | +1 617-301-1869 |
| 43228 | Peter Waibel | +1 862-778-7838 |
| 46473 | Emily Wu | +1 858-812-1539 |
| 46593 | Laurie Lawrence | +1 617-871-8584 |
| 48631 | Carol Fang | +1 650-467-2901 |
| 51681 | Mark Flanigan | +1 817-615-5080 |
| 53504 | Daniel Raymond | +1 858-812-1617 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 8 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 9,220,631 Asserted | Asserted Patent | View Official Patent → |
| ๐ช๐บ European Patent Office (UPC States) | EP 12,174,860 | European Counterpart (EP) | View Official Patent → |
| ๐ช๐บ European Patent Office (UPC States) | EP 12,189,649 | European Counterpart (EP) | View Official Patent → |
| ๐ฉ๐ช Germany | DE 2020120110 | Germany Counterpart | View Official Patent → |
| ๐ฉ๐ช Germany | DE 2020120112 | Germany Counterpart | View Official Patent → |
| ๐ช๐บ European Patent Office (UPC States) | EP 12,195,360 | European Counterpart (EP) | View Official Patent → |
| ๐ฉ๐ช Germany | DE 2013200006 | Germany Counterpart | View Official Patent → |
| ๐ฉ๐ช Germany | DE 2020130006 | Germany Counterpart | View Official Patent → |
Regeneron Pharmaceuticals, Inc. et al. v. Novartis Pharma AG et al.
Regeneron Pharmaceuticals, Inc. v. Novartis Pharma AG et al.